Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952.
暂无分享,去创建一个
H. Sather | P. Gaynon | M. La | L. Stork | S. Malempati
[1] E. Mejstrikova,et al. Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia , 2007, Pediatric blood & cancer.
[2] M. Loh,et al. Factors Influencing Survival after Relapse from Childhood ALL: A Children’s Oncology Group Study. , 2006 .
[3] N. Heerema,et al. Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: Results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group , 2006 .
[4] M. Devidas,et al. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] David Steele,et al. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941. , 2006, Journal of Clinical Oncology.
[6] M. Devidas,et al. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. , 2005, Blood.
[7] R. Arceci,et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[8] Ulrich Göbel,et al. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] R. Larson,et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[10] Jun Okamura,et al. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: Impact of allogeneic stem cell transplantation—a report from the Kyushu‐Yamaguchi Children's Cancer Study Group , 2005, Pediatric blood & cancer.
[11] M. Relling,et al. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia , 2005, Cancer.
[12] D. Campana,et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse , 2004, Leukemia.
[13] P. Veys,et al. Long‐term follow‐up of relapsed childhood acute lymphoblastic leukaemia , 2003, British journal of haematology.
[14] A. Cnaan,et al. Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: A Pediatric Blood and Marrow Transplant Consortium study , 2003, Bone Marrow Transplantation.
[15] N. Heerema,et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. , 2003, Blood.
[16] G. Henze,et al. Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis. , 2003, Blood.
[17] N. Sacchi,et al. Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors , 2002, Leukemia.
[18] M. Bleakley,et al. Allogeneic bone marrow transplantation for childhood relapsed acute lymphoblastic leukemia: comparison of outcome in patients with and without a matched family donor , 2002, Bone Marrow Transplantation.
[19] C. Pui. Risk assessment in acute lymphoblastic leukemia: beyond leukemia cell characteristics. , 2001, Journal of pediatric hematology/oncology.
[20] D. Campana,et al. Childhood acute lymphoblastic leukaemia--current status and future perspectives. , 2001, The Lancet. Oncology.
[21] B. Pollock,et al. Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a pediatric oncology group study , 2000 .
[22] S. Richards,et al. Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[23] R. Meek,et al. Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia. , 2000, Medical and pediatric oncology.
[24] B. Pollock,et al. Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission , 2000, Cancer.
[25] B. Pollock,et al. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study . , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] J. Román,et al. Allogeneic bone marrow transplantation vs chemotherapy for the treatment of childhood acute lymphoblastic leukaemia in second complete remission (revisited 10 years on) , 1999, Bone Marrow Transplantation.
[27] G. Gustafsson,et al. Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries , 1999, Bone Marrow Transplantation.
[28] P. Steinherz,et al. Survival after relapse in childhood acute lymphoblastic leukemia , 1998, Cancer.
[29] S. Richards,et al. Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience , 1998, British journal of haematology.
[30] D. Srivastava,et al. Outcomes of transplantation with matched-sibling and unrelateddonor bone marrow in children with leukaemia , 1997, The Lancet.
[31] L. Robison,et al. Incidence of cancer in children in the United States. Sex‐, race‐, and 1‐year age‐specific rates by histologic type , 1995, Cancer.
[32] G. Henze,et al. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group. , 1995, Bone marrow transplantation.
[33] A. Zwinderman,et al. Case-control analysis of allogeneic bone marrow transplantation versus maintenance chemotherapy for relapsed ALL in children. , 1995, Bone marrow transplantation.
[34] J. Shuster,et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. , 1994, The New England journal of medicine.
[35] S. Smith,et al. Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1993, Blood.
[36] W. Friedrich,et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. , 1991, Blood.
[37] C. Herrera,et al. Allogeneic bone marrow transplantation versus chemotherapy in the treatment of childhood acute lymphoblastic leukemia in second complete remission. , 1989, Bone marrow transplantation.
[38] J. Sanders,et al. Marrow transplantation for children with acute lymphoblastic leukemia in second remission , 1987 .
[39] J. Wagner,et al. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] P. Steinherz,et al. Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] C. Pui,et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.